8-K 1 d94704e8-k.txt FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT: MARCH 5, 2002 COLORADO MEDTECH, INC. ---------------------- (Exact name of registrant as specified in its charter) COLORADO 000-12471 84-0731006 (State or other jurisdiction (Commission File I.R.S. Employer of incorporation) Number) Identification No.) 6175 LONGBOW DRIVE BOULDER, COLORADO 80301 ----------------------- (Address, including zip code, of principal executive offices) (303) 530-2660 -------------- (Registrant's telephone number, including area code) ITEM 5. OTHER EVENTS. Colorado MEDtech, Inc. issued a press release regarding the settlement of a dispute and litigation with Gen-Probe Incorporated. The text of the press release is attached hereto as Exhibit 99.1. ITEM 7. FINANCIAL STATEMENT AND EXHIBITS. (c) Exhibits. No. Description --- ----------- 99.1 Press release dated March 5, 2002 -2- SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DATED, this 5th day of March, 2002. COLORADO MEDTECH, INC. By: /s/ Stephen K. Onody ----------------------------- Stephen K. Onody President and CEO -3- INDEX TO EXHIBITS
EXHIBIT NUMBER DESCRIPTION ------- ----------- 99.1 Press release dated March 5, 2002